MicroRNAs in diabetes and diabetes-associated complications

Area of Science:

• Biochemistry
• Molecular Biology
• Endocrinology

Background:

• Diabetes mellitus presents significant socioeconomic challenges due to high prevalence and severe complications.
• Microvascular and macrovascular complications, including nephropathy, cardiomyopathy, neuropathy, and retinopathy, are hallmarks of diabetes.
• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are frequently dysregulated in disease states.

Purpose of the Study:

• To review the current understanding of microRNA involvement in the pathogenesis of diabetes mellitus.
• To explore the impact of microRNAs on diabetes-associated complications.
• To summarize the role of microRNAs in pancreatic beta cell function, endothelial and vascular smooth muscle cell dysfunction, diabetic cardiomyopathy, nephropathy, and skeletal muscle and hepatic involvement.

Main Methods:

• Literature review and synthesis of existing research.
• Analysis of studies investigating microRNA expression and function in diabetes models and patients.
• Compilation of data on microRNA targets and pathways relevant to diabetic complications.

Main Results:

• MicroRNAs are demonstrably dysregulated in diabetes and its complications.
• Specific microRNAs influence key processes such as insulin secretion, glucose metabolism, and vascular integrity.
• Evidence links microRNAs to endothelial dysfunction, cardiac remodeling, kidney damage, and altered metabolic function in skeletal muscle and liver.

Conclusions:

• MicroRNAs play a critical role in the development and progression of diabetes mellitus and its associated pathologies.
• Targeting microRNAs presents a potential therapeutic strategy for managing diabetes and its complications.
• Further research into microRNA mechanisms is essential for developing effective interventions.